SEQENS
Benjamin Schneider is an experienced professional in the pharmaceutical and agricultural sectors, currently serving as a Portfolio Manager at SEQENS since April 2018. Previous roles include Account Manager Europe at Teva Pharmaceuticals and various positions at ADAMA Agricultural Solutions Ltd, including Global Product Manager, Head of IP Department, and Patent Attorney. Schneider also held positions at Perrigo as Portfolio Manager and Patent Attorney, along with a role as Business Development New Projects Manager at ChemAgis, an API Division of Perrigo. An academic background includes an MBA in Marketing from Peres Academic Center, as well as MSc and BSc degrees in Organic Chemistry and Chemistry from Tel Aviv University, respectively.
This person is not in any offices
SEQENS
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.4 MM€ and operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. 3,400 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.